Charles Schwab Investment Management Inc Axsome Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 322,596 shares of AXSM stock, worth $29.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

322,596

Previous 309,818 4.12%

Holding current value

$29.3 Million

Previous $24.9 Million 16.22%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$78.93 - $95.84 $1.01 Million - $1.22 Million	12,778 Added 4.12%	322,596 $29 Million
Q2 2024 Aug 12, 2024	BUY	$65.72 - $80.5 $574,655 - $703,892	8,744 Added 2.9%	309,818 $24.9 Million
Q1 2024 May 08, 2024	BUY	$69.39 - $97.64 $372,832 - $524,619	5,373 Added 1.82%	301,074 $24 Million
Q4 2023 Feb 06, 2024	BUY	$57.42 - $83.61 $334,758 - $487,446	5,830 Added 2.01%	295,701 $23.5 Million
Q3 2023 Nov 08, 2023	BUY	$69.25 - $82.21 $1.49 Million - $1.76 Million	21,457 Added 7.99%	289,871 $20.3 Million
Q2 2023 Aug 09, 2023	BUY	$58.41 - $90.35 $1.13 Million - $1.74 Million	19,296 Added 7.75%	268,414 $19.3 Million
Q1 2023 May 11, 2023	SELL	$58.39 - $75.0 $38,070 - $48,900	-652 Reduced 0.26%	249,118 $15.4 Million
Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $935,274 - $1.87 Million	23,417 Added 10.35%	249,770 $19.3 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $435,136 - $842,879	12,067 Added 5.63%	226,353 $10.1 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $23,327 - $50,162	1,073 Added 0.5%	214,286 $8.21 Million
Q1 2022 May 13, 2022	BUY	$23.7 - $41.39 $141,797 - $247,636	5,983 Added 2.89%	213,213 $8.83 Million
Q4 2021 Feb 11, 2022	BUY	$30.7 - $43.36 $97,564 - $137,798	3,178 Added 1.56%	207,230 $7.83 Million
Q3 2021 Nov 16, 2021	BUY	$19.91 - $68.26 $357,523 - $1.23 Million	17,957 Added 9.65%	204,052 $6.73 Million
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $164,699 - $239,095	3,253 Added 1.78%	186,095 $12.6 Million
Q1 2021 May 17, 2021	BUY	$55.91 - $81.44 $311,698 - $454,028	5,575 Added 3.14%	182,842 $10.4 Million
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $122,938 - $160,408	1,854 Added 1.06%	177,267 $14.4 Million
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $384,549 - $483,021	-5,627 Reduced 3.11%	175,413 $12.5 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $658,782 - $1.3 Million	13,210 Added 7.87%	181,040 $14.9 Million
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $315,262 - $775,224	7,652 Added 4.78%	167,830 $9.87 Million
Q4 2019 Feb 07, 2020	BUY	$16.71 - $106.24 $128,115 - $814,542	7,667 Added 5.03%	160,178 $16.6 Million
Q3 2019 Nov 08, 2019	BUY	$20.24 - $29.16 $1.94 Million - $2.79 Million	95,814 Added 168.99%	152,511 $3.09 Million
Q2 2019 Aug 09, 2019	BUY	$13.46 - $25.75 $763,141 - $1.46 Million	56,697 New	56,697 $1.46 Million

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Axsome Therapeutics, Inc. Transaction History